0001209191-23-023472.txt : 20230405 0001209191-23-023472.hdr.sgml : 20230405 20230405191620 ACCESSION NUMBER: 0001209191-23-023472 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220403 FILED AS OF DATE: 20230405 DATE AS OF CHANGE: 20230405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krueger Christopher W CENTRAL INDEX KEY: 0001394208 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40928 FILM NUMBER: 23803959 MAIL ADDRESS: STREET 1: C/O ARDEA BIOSCIENCES INC STREET 2: 2131 PALOMAR AIRPORT ROAD SUITE 300 CITY: CARLSBAD STATE: CA ZIP: 92011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ventyx Biosciences, Inc. CENTRAL INDEX KEY: 0001851194 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832996852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 662 ENCINITAS BLVD., STE. 250 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: (858) 945-2393 MAIL ADDRESS: STREET 1: 662 ENCINITAS BLVD., STE. 250 CITY: ENCINITAS STATE: CA ZIP: 92024 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2022-04-03 0 0001851194 Ventyx Biosciences, Inc. VTYX 0001394208 Krueger Christopher W C/O VENTYX BIOSCIENCES, INC. 662 ENCINITAS BLVD, SUITE 250 ENCINITAS CA 92024 0 1 0 0 Chief Business Officer 0 Common Stock 2022-04-03 4 M 0 7972 3.54 A 290642 D Common Stock 2022-04-03 4 M 0 475 8.04 A 291117 D Common Stock 2022-04-03 4 S 0 15000 32.8777 D 276117 D Stock Option (Right to Buy) 3.54 2023-04-03 4 M 0 7972 0.00 D 2021-02-26 2031-02-26 Common Stock 7972 0 D Stock Option (Right to Buy) 8.04 2023-04-03 4 M 0 475 0.00 D 2031-09-18 Common Stock 475 170176 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022. Represents the weighted average share price of an aggregate total of 15,000 shares sold in the price range of $32.5744 to $33.495. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the options shall vest on the one year anniversary of the Vesting Commencement date, and, thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean September 17, 2021. /s/ Christopher Krueger 2023-04-05